Reports/LON:SUP
LON:SUP

LON:SUP - Supreme PLC

BUYAWAIT ENTRYIndustrials - Electrical Equipment & Parts2026-08-11Data 32 days old141.00p
65
Conviction
out of 100

Executive Summary

Supreme PLC (LON:SUP) is a London-listed supplier of branded and own-label consumer products operating across electrical equipment and parts, with activities spanning batteries, lighting, vaping and related categories. The group sits within the broader UK branded goods consolidator cohort and is positioned as a smaller, acquisitive operator building scale through targeted bolt-on deals and licensed product extensions.

The investment case rests on the integration of completed acquisitions and the ramp of named licensing deals translating into sustained earnings growth from a low earnings multiple. The key near-term catalyst is the delivery of the next set of full-year results, building on the record FY26 performance reported for the year to 31 March 2026 where revenue was indicated to be rising ahead of expectations; any further guidance update from management would re-anchor expectations. The primary risk is a stalling in earnings momentum: the analyst reasoning flags a filing-disclosed -0.5% earnings growth risk that, if it crystallises, would undermine the current valuation case despite the 9.02 P/E.

BUY. Conviction Score: 65/100. The view would change to a more cautious stance if reported earnings growth turns meaningfully negative on a sustained basis, or if a sizeable acquisition is funded in a way that compromises the group's net cash position.

Wait for entry. Current price 141.00p is 5.5% above the buy ceiling of 133.67p. New positions only below the ceiling.
AWAIT ENTRYBUY · 65/100Now 141.00p · buy ≤ 133.67p · trim ≥ 165.00p

Thesis break: The thesis would be invalidated by a sustained period of negative reported earnings growth combined with erosion of the group's net cash position, or by a material adverse regulatory change that structurally impairs the vaping segment's contribution.

Business Model

Supreme PLC generates revenue by sourcing, branding and distributing consumer products across several adjacent categories, including batteries, lighting, vaping devices and accessories, and other electrical components. The group operates a hybrid model combining own-label manufacturing and distribution with brand licensing arrangements, which allows it to extend its portfolio without carrying the full capital cost of new product development in every category.

Customers are primarily UK and European retailers and wholesalers who buy either Supreme's own-label lines or licensed brands on a volume basis. The economics are volume-led, with margins driven by the mix between higher-margin licensed and branded product versus more commoditised own-label volume. Management commentary referenced in the research indicates a gross profit margin of approximately 29% in the latest reporting period, down roughly 3 percentage points year-on-year owing to a shift in product mix within the vaping division, with a final dividend of 3.8 pence per share proposed, up 4% year-on-year, reflecting continued cash generation.

The competitive moat is relatively modest in any single category but is reinforced by distribution relationships, brand licences and the group's acquisitive roll-up strategy, which has historically delivered earnings-accretive deals. Remaining net cash positive, as flagged in the analyst reasoning, provides balance sheet optionality for further bolt-on activity or capital return, and underpins the current investment proposition of a cash-generative platform trading on a low earnings multiple.

Financial Snapshot

Price
141.00p
Market Cap
165.4m
P/E Ratio
9.4x
52w High
195.00p
52w Low
123.00p
Distance from 52wH
-27.7%
Avg Volume
161253
Currency
GBX

Recent Catalysts

[31 March 2026 (FY26)] - Supreme PLC reported a record performance for the financial year to 31 March 2026, with revenue indicated to be rising ahead of expectations, alongside a proposed final dividend of 3.8p per share, up 4% year-on-year, despite a roughly 3 percentage point gross margin contraction to 29% owing to vaping product mix. Source: TipRanks / company announcement coverage.

[7 May 2026] - Shore Capital Group reaffirmed a "house stock" rating on Supreme PLC in a research note, sustaining broker endorsement at a time when the shares trade well below the 52-week high. Source: MarketBeat coverage of Shore Capital research note.

[29 November 2022 (historical reference)] - Supreme PLC released its unaudited half-year results for the period, an earlier data point in the group's reporting history used here only as a reference marker for the cadence of interim disclosures. Source: RNS announcement (Refinitiv newsfile).

Thesis Evaluation

Bull Case (33% weight)

Acquisitions already completed integrate cleanly, named licensing deals ramp materially through FY27, and gross margin recovers from the 29% level as vaping mix normalises. Net cash is redeployed into further earnings-accretive bolt-ons rather than dilutive equity issuance. On those conditions, the shares re-rate toward the broader analyst target area referenced at 237p. Price target: 237p, 12-month horizon.

Base Case (48% weight)

Revenue and earnings continue to grow at a measured pace from the FY26 record base, the gross margin stabilises near 29%, and the group remains net cash positive with modest dividend progression. The valuation multiple holds near the current low-double-digit P/E rather than re-rating sharply. Price target: 165p, 12-month horizon.

Bear Case (19% weight)

The filing-flagged -0.5% earnings growth risk crystallises, vaping mix continues to weigh on gross margin, and integration costs from recent deals suppress reported earnings. Without fresh hard catalysts, the multiple derates and the share price retraces toward the 52-week low. Price target: 118p, 12-month horizon.

Weighted conviction:Bull (33%) x 100 + Base (48%) x 62 + Bear (19%) x 10 = 65/100. BUY.

Key Risks

  1. Earnings growth stall: Analyst reasoning flags a filing-disclosed -0.5% earnings growth risk which, if it persists, would undermine the case for the current 9.02 P/E multiple. Estimated probability: 35%. Impact: moderate.
  2. Gross margin pressure from vaping mix: Gross profit margin contracted by approximately 3 percentage points to 29% owing to a shift in product mix within the vaping division, and a further adverse mix shift could compress profitability further. Estimated probability: 30%. Impact: moderate.
  3. Acquisition integration risk: The investment case leans on earnings-accretive M&A and the integration of completed deals; integration disruption, goodwill impairment or overpayment for targets would erode the bull case. Estimated probability: 25%. Impact: severe.
  4. Regulatory exposure in vaping: A material portion of margin pressure is tied to the vaping category, which is subject to evolving UK and European regulation that could constrain volumes, marketing or product formats. Estimated probability: 25%. Impact: severe.
  5. Liquidity and float risk: As a smaller London-listed group, Supreme PLC may face lower trading liquidity and higher share price volatility around results, which can amplify drawdowns in a bear scenario. Estimated probability: 40%. Impact: low.

Who Should Own It / Avoid It

Ideal for: Long-term UK equity investors comfortable with small-cap, acquisitive consumer brands, with a minimum holding period of 12 to 18 months to allow acquisition integration and licensing ramps to flow through reported earnings. A moderate risk tolerance is required given the single-digit P/E valuation reflects some caution already, and investors should be able to tolerate interim volatility around results and regulatory news in the vaping category.

Avoid if: Investors seeking large-cap, highly liquid, dividend-heavy blue-chip exposure, or those unable to stomach a -0.5% earnings outcome combined with category-specific regulatory risk. Short-term traders looking for catalyst-driven momentum rather than multi-quarter integration plays should also avoid, as the case relies on completed deals bedding in over time rather than near-term rerating alone.

Recommendation

BUY - 65/100. The tier reflects a positive view anchored on a low 9.02 P/E, the FY26 record results, net cash position and identifiable licensing and acquisition catalysts, tempered by the filing-flagged -0.5% earnings growth risk and category mix headwinds. The call would be upgraded toward a higher conviction on evidence of clean acquisition integration, a sustained recovery in gross margin from 29%, and a clear update on named licensing deals. It would be downgraded if reported earnings turn meaningfully negative on a sustained basis, if the net cash position is materially eroded by a dilutive raise, or if regulatory action in the vaping category forces a structural reset of that segment's contribution. At the current price of 141.00p the shares trade above our buy ceiling of 133.67p: the thesis is credible but the price is not - new positions only below that level.

The probability-weighted value across our three scenarios is 179.83p, 28% above the current price of 141.00p - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below 133.67p - below this level the upside to the base-case target (165.00p) is at least 2x the downside to the bear case (118.00p), the minimum risk/reward we require before committing new capital.

HOLD

between 133.67p and 165.00p - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above 165.00p - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 33%.

SELL

if the thesis would be invalidated by a sustained period of negative reported earnings growth combined with erosion of the group's net cash position, or by a material adverse regulatory change that structurally impairs the vaping segment's contribution, regardless of price - the bear target of 118.00p is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 65/100. Trend versus prior report: Up.

CONVBUYOPPSPECAVOID1007550250Conviction (0-100)2026-04-282026-05-302026-06-282026-07-252026-08-11
CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)
Report dateConviction
2026-08-1165
2026-07-2559
2026-06-2864
2026-05-3078
2026-04-2864

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Coverage of Supreme PLC's FY26 record results announcement, Shore Capital's reaffirmation of its house stock rating in May 2026, public news flow on the London listing, and broader market commentary on UK small-cap consumer brands were drawn upon to characterise sentiment and information flow around the name.

Primary source types: Company announcements and press releases, RNS regulatory announcements, earnings call transcripts and earnings coverage, third-party broker research notes, and investor relations materials referenced via financial news platforms.

Key sources

Data correct as of 2026-08-11